GRI - GRI Bio, Inc. - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

158.6M

Cash

9.00K

Avg Qtr Burn

-271.3K

Short % of Float

0.82%

Insider Ownership

28.24%

Institutional Own.

2.02%

Qtr Updated

12/31/22

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
GRI-0621 Details Idiopathic pulmonary fibrosis, Lung disease	Phase 2a Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
GRI-0803 Details Autoimmune disease, Systemic lupus erythematosus	IND Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.